-
Brazil's Lula discharged after cataract surgery
-
US Senate races to limit shutdown fallout as Trump-backed deal stalls
-
'He probably would've survived': Iran targeting hospitals in crackdown
-
Djokovic stuns Sinner to set up Australian Open final with Alcaraz
-
Mateta omitted from Palace squad to face Forest
-
Gold, silver prices tumble as investors soothed by Trump's Fed pick
-
Trump attorney general orders arrest of ex-CNN anchor covering protests
-
Djokovic 'pushed to the limit' in stunning late-night Sinner upset
-
Tunisia's famed blue-and-white village threatened after record rains
-
Top EU official voices 'shock' at Minneapolis violence
-
Kremlin says agreed to halt strikes on Kyiv until Sunday
-
Carrick calls for calm after flying start to Man Utd reign
-
Djokovic to meet Alcaraz in Melbourne final after five-set marathon
-
Italian officials to testify in trial over deadly migrant shipwreck
-
Iran says defence capabilities 'never' up for negotiation
-
UN appeals for more support for flood-hit Mozambicans
-
Lijnders urges Man City to pile pressure on Arsenal in title race
-
Fulham sign Man City winger Oscar Bobb
-
Strasbourg's Argentine striker Panichelli sets sights on PSG, World Cup
-
Jesus 'made love': Colombian president irks Christians with steamy claim
-
IAEA board meets over Ukraine nuclear safety concerns
-
Eurozone growth beats 2025 forecasts despite Trump woes
-
Israel to partially reopen Gaza's Rafah crossing on Sunday
-
Dutch PM-elect Jetten says not yet time to talk to Putin
-
Social media fuels surge in UK men seeking testosterone jabs
-
Forest face Fenerbahce, Celtic draw Stuttgart in Europa League play-offs
-
US speed queen Vonn crashes at Crans-Montana, one week before Olympics
-
Trump nominates former US Fed official as next central bank chief
-
Alcaraz defends controversial timeout after beaten Zverev fumes
-
New Dutch government pledges ongoing Ukraine support
-
Newcastle still coping with fallout from Isak exit, says Howe
-
Chad, France eye economic cooperation as they reset strained ties
-
Real Madrid to play Benfica, PSG face Monaco in Champions League play-offs
-
Everton winger Grealish set to miss rest of season in World Cup blow
-
Trump brands Minneapolis nurse killed by federal agents an 'agitator'
-
Arteta focuses on the positives despite Arsenal stumble
-
Fijian Drua sign France international back Vakatawa
-
Kevin Warsh, a former Fed 'hawk' now in tune with Trump
-
Zverev rails at Alcaraz timeout in 'one of the best battles ever'
-
Turkey leads Iran diplomatic push as Trump softens strike threat
-
Zelensky backs energy ceasefire, Russia bombs Ukraine despite Trump intervention
-
'Superman' Li Ka-shing, Hong Kong billionaire behind Panama ports deal
-
Skiing great Lindsey Vonn crashes at Crans-Montana, one week before Olympics
-
Slot warns Liverpool 'can't afford mistakes' in top-four scrap
-
Paris show by late Martin Parr views his photos through political lens
-
'Believing' Alcaraz outlasts Zverev in epic to reach maiden Melbourne final
-
Artist chains up thrashing robot dog to expose AI fears
-
Alcaraz outlasts Zverev in epic to reach maiden Australian Open final
-
French PM forces final budget through parliament
-
French-Nigerian artists team up to craft future hits
| SCS | 0.12% | 16.14 | $ | |
| RBGPF | 1.65% | 83.78 | $ | |
| BCC | -1.22% | 79.2 | $ | |
| NGG | -0.12% | 84.95 | $ | |
| GSK | 0.99% | 51.16 | $ | |
| CMSC | -0.02% | 23.69 | $ | |
| JRI | 0.15% | 12.975 | $ | |
| BP | 0.44% | 38.21 | $ | |
| RIO | -2.83% | 92.51 | $ | |
| BTI | -0.54% | 59.885 | $ | |
| RELX | -1.22% | 35.73 | $ | |
| BCE | 0.27% | 25.555 | $ | |
| CMSD | -0.04% | 24.05 | $ | |
| RYCEF | -2.69% | 16 | $ | |
| VOD | -0.41% | 14.65 | $ | |
| AZN | 0.29% | 92.855 | $ |
Understanding When to Use Fillers or Neurotoxins According to Dr. Ran Rubinstein
Dr. Ran Rubinstein discusses how individualized treatment planning determines when fillers, neurotoxins, or collagen-stimulating injectables are most appropriate.
MONTVALE, NEW JERSEY / ACCESS Newswire / January 30, 2026 / Injectable aesthetic treatments continue to grow in popularity, yet confusion remains around when dermal fillers are appropriate versus when neurotoxins are the better option. Facial plastic surgeon and national injectables trainer Dr. Ran Rubinstein emphasizes that understanding how these treatments differ is essential to achieving natural, balanced results.
As a board-certified facial plastic surgeon certified by the American Board of Facial Plastic and Reconstructive Surgery, Dr. Rubinstein notes that fillers and neurotoxins work through distinct biological mechanisms and must be selected based on facial anatomy, movement patterns, and long-term aesthetic goals.

Fillers and Neurotoxins Serve Different Purposes
Although both fillers and neurotoxins are injectable treatments, they address facial aging in fundamentally different ways.
Dermal fillers, most commonly injectable hyaluronic acid (HA) fillers, are designed to add volume, restore contour, or enhance facial definition. Neurotoxins, such as botulinum toxin products, work by relaxing targeted muscles to soften expression-related lines. While both treatments can improve the appearance of wrinkles, they do so through distinct processes that require different planning considerations.
Not All Dermal Fillers Are the Same
One of the most common misconceptions Dr. Rubinstein encounters is the belief that all injectable HA fillers function the same way. In practice, dermal fillers vary widely in texture, flexibility, and structural support, which is why careful product selection is essential.
Different HA fillers are selected based on:
The specific area of the face being treated
The amount of movement in that area
Whether the goal is subtle refinement or structural support
Some fillers are soft and flexible to accommodate natural facial movement, while others provide firmer support for contouring and definition. Proper product selection allows results to look balanced and natural rather than overfilled. This individualized approach to dermal fillers reflects the importance of injector expertise and facial anatomy knowledge.
Biostimulators and HA Fillers Are Not Interchangeable
Another area of confusion involves biostimulators and their role in facial rejuvenation. While biostimulators and injectable hyaluronic acid (HA) fillers are often discussed together, they serve different purposes and are selected based on distinct treatment goals.
Biostimulatory injectables are designed to stimulate the body's natural collagen production over time. Rather than creating immediate volume, they support gradual structural improvement and skin quality changes as collagen develops. For many patients, this approach offers:
More subtle, progressive enhancement
Longer-lasting improvement driven by collagen remodeling
A natural evolution of results over time rather than instant change
Because collagen production occurs gradually, biostimulatory treatments may require multiple sessions and patience before results are fully visible. They are often chosen for patients seeking long-term support rather than immediate contour correction.
Injectable HA fillers, by contrast, are frequently used when precise placement and immediate volume or definition are desired. Their ability to deliver targeted structural support makes them well suited for specific facial areas where contour and balance need to be addressed directly.
Understanding the complementary roles of biostimulators and HA fillers allows treatment plans to be tailored rather than standardized, ensuring each approach is used where it delivers the most appropriate and natural outcome.
Understanding Cost, Longevity, and Value
Concerns about cost often influence patient decision-making. Dr. Rubinstein notes that injectable treatments should be evaluated based on longevity, precision, and outcomes rather than upfront pricing alone.
Most injectable HA filler treatments are performed in-office in under an hour, with results that may last a year or longer depending on the product used and the treatment area. When considered over time, many patients find that the durability and quality of results justify the investment.
Fillers Are Used Beyond the Lips
Dermal fillers are frequently associated only with lip enhancement, but their applications extend far beyond that single area. Injectable HA fillers can be used to address a range of facial concerns, including:
Under-eye hollowing
Cheek contour and midface volume
Lower facial lines and folds
Chin structure and projection
Each treatment area requires careful evaluation of facial proportions and product selection to maintain harmony across the face.
The Key Difference Between Fillers and Neurotoxins
A foundational distinction Dr. Rubinstein emphasizes is how fillers and neurotoxins achieve their effects.
Fillers add volume or definition and often produce immediate visible changes. Neurotoxins reduce muscle movement, with results developing gradually over several days to weeks. While both treatments can smooth lines or wrinkles, they address different causes of facial aging and are frequently used together as part of a comprehensive treatment plan.
Expertise Matters in Injectable Treatment Planning
Dr. Rubinstein's approach to injectables is rooted in education, safety, and anatomical precision. As a national trainer, he works with medical professionals across the country to advance best practices in aesthetic injection techniques. This role underscores the importance of individualized treatment planning and ongoing education in a rapidly evolving field.
Located in Montvale, New Jersey, Rubinstein Plastic Surgery Center focuses exclusively on facial plastic surgery and facial rejuvenation procedures. The practice offers injectable treatments designed to enhance facial balance while preserving natural expression.
Educational insights and professional updates from Dr. Rubinstein are shared through the practice's official Instagram account, where injectable concepts and facial anatomy considerations are discussed for both patients and medical professionals.
Patients interested in learning more about facial injectables or scheduling a consultation can connect with the practice through the contact page.
About Dr. Ran Rubinstein
Dr. Ran Rubinstein is a board-certified facial plastic surgeon specializing exclusively in facial procedures and facial injectables. He is certified by the American Board of Facial Plastic and Reconstructive Surgery and trained in Otolaryngology-Head and Neck Surgery. Dr. Rubinstein is recognized nationally as an injectables trainer and educator, with a focus on precision, safety, and natural-appearing results.
Media Contact
Dr. Ran Rubinstein
(201) 391-1135
[email protected]
SOURCE: Rubinstein Plastic Surgery Center
View the original press release on ACCESS Newswire
H.Thompson--AT